1
|
Yu Y, Li J, Zou Y, Yin R. 5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) for acneform rash induced by erlotinib: A case report. Photodiagnosis Photodyn Ther 2022; 39:102994. [PMID: 35792252 DOI: 10.1016/j.pdpdt.2022.102994] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Revised: 06/28/2022] [Accepted: 06/29/2022] [Indexed: 01/10/2023]
Abstract
Erlotinib is an anticancer drug approved for the treatment of non-small cell lung cancer. It inhibits growth and proliferation of tumor cells by targeting epidermal growth factor receptor (EGFR). Dermatological toxicities are common side effects associated with EGFR inhibition. Here we describe a patient with acneform rash following oral medication of erlotinib, presented as facial erythema, papules and pustules. Two sessions of 5-aminolevulinic acid induced photodynamic therapy (ALA-PDT) with a 2-week interval were performed. No significant side effects or scarring were observed. The patient showed no recurrence within 6 months. Thus, we conclude that ALA-PDT is an effective treatment for skin lesions induced by erlotinib, especially for patients with need to sustain medication.
Collapse
Affiliation(s)
- Yanlan Yu
- Department of Dermatology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China
| | - Junzhao Li
- Department of Dermatology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China
| | - Yongzhen Zou
- Department of Dermatology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China
| | - Rui Yin
- Department of Dermatology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.
| |
Collapse
|
2
|
Ding J, Mellergaard M, Zhu Z, Kwan P, Edge D, Ma Z, Hebert L, Alrobaiea S, Iwasaki T, Nielsen MCE, Tredget EE. Fluorescent light energy modulates healing in skin grafted mouse model. Open Med (Wars) 2021; 16:1240-1255. [PMID: 34522783 PMCID: PMC8402934 DOI: 10.1515/med-2021-0329] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2021] [Revised: 06/11/2021] [Accepted: 07/07/2021] [Indexed: 12/25/2022] Open
Abstract
Skin grafting is often the only treatment for skin trauma when large areas of tissue are affected. This surgical intervention damages the deeper dermal layers of the skin with implications for wound healing and a risk of scar development. Photobiomodulation (PBM) therapy modulates biological processes in different tissues, with a positive effect on many cell types and pathways essential for wound healing. This study investigated the effect of fluorescent light energy (FLE) therapy, a novel type of PBM, on healing after skin grafting in a dermal fibrotic mouse model. Split-thickness human skin grafts were transplanted onto full-thickness excisional wounds on nude mice. Treated wounds were monitored, and excised xenografts were examined to assess healing and pathophysiological processes essential for developing chronic wounds or scarring. Results demonstrated that FLE treatment initially accelerated re-epithelialization and rete ridge formation, while later reduced neovascularization, collagen deposition, myofibroblast and mast cell accumulation, and connective tissue growth factor expression. While there was no visible difference in gross morphology, we found that FLE treatment promoted a balanced collagen remodeling. Collectively, these findings suggest that FLE has a conceivable effect at balancing healing after skin grafting, which reduces the risk of infections, chronic wound development, and fibrotic scarring.
Collapse
Affiliation(s)
- Jie Ding
- Wound Healing Research Group, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, 161 HMRC, Edmonton, Canada
| | - Maiken Mellergaard
- Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
- Department of Research and Development, Klox Technologies Europe Ltd, Dublin, Ireland
| | - Zhensen Zhu
- Wound Healing Research Group, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, 161 HMRC, Edmonton, Canada
| | - Peter Kwan
- Wound Healing Research Group, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, 161 HMRC, Edmonton, Canada
| | - Deirdre Edge
- Department of Research and Development, Klox Technologies Europe Ltd, Dublin, Ireland
| | - Zengshuan Ma
- Wound Healing Research Group, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, 161 HMRC, Edmonton, Canada
| | - Lise Hebert
- Department of Research and Development, Klox Technologies Inc., Laval, Canada
| | - Saad Alrobaiea
- Wound Healing Research Group, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, 161 HMRC, Edmonton, Canada
| | - Takashi Iwasaki
- Wound Healing Research Group, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, 161 HMRC, Edmonton, Canada
| | - Michael Canova Engelbrecht Nielsen
- Department of Research and Development, Klox R&D Center, Guangdong Klox Biomedical Group Co., Ltd, Room 603, 6/F, Building 8, No. 6, Nanjiang Second Road, Zhujiang Street, Nansha District, Guangzhou, China
| | - Edward E. Tredget
- Divisions of Plastic and Reconstructive Surgery and Critical Care, 2D2.28 Walter C MacKenzie Health Sciences Centre & Wound Healing Research Group, 161 HMRC, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
| |
Collapse
|
3
|
Wade M, Charest V, Ballardin B, Edge D, Nielsen MCE. Biophotonic Therapy with Fluorescent Light Energy Decreases Facial Erythema, Improves Signs and Symptoms of Rosacea, and Increases Patient Satisfaction: A Postmarket Study. THE JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY 2021; 14:16-21. [PMID: 34840644 PMCID: PMC8570353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
BACKGROUND Rosacea is a difficult-to-manage chronic inflammatory skin condition reported to have a negative psychosocial impact on patients. Novel approaches are sought to target the many signs and symptoms of the condition while also improving the quality of life of patients. OBJECTIVE We assessed the efficacy of the Kleresca® biophotonic platform (KLOX Technologies Inc., Laval, Canada), which creates fluorescent light energy (FLE), to induce a novel form of photobiomodulation for treating rosacea. We also assessed patient satisfaction with their facial appearance and concerns about perceptions of others before and after treatment. METHODS Nine patients were treated once a week for four weeks with FLE. Patients and the treating clinician completed questionnaires throughout and after the treatment to grade the rosacea signs and symptoms and capture patients' perceptions of the treatment and their condition. RESULTS FLE significantly reduced the inflammatory erythematous reaction of the face, improved flushing and erythema associated with rosacea, and had a positive impact on patients' self-perception and emotional wellbeing. CONCLUSION Our results support FLE as an effective, noninvasive treatment modality for rosacea.
Collapse
Affiliation(s)
- Martin Wade
- Dr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England
- Drs. Edge and Nielsen are with Guangdong Klox Biomedical Group Co., Ltd., in Guangzhou, China
| | - Vanessa Charest
- Dr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England
- Drs. Edge and Nielsen are with Guangdong Klox Biomedical Group Co., Ltd., in Guangzhou, China
| | - Bruno Ballardin
- Dr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England
- Drs. Edge and Nielsen are with Guangdong Klox Biomedical Group Co., Ltd., in Guangzhou, China
| | - Deirdre Edge
- Dr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England
- Drs. Edge and Nielsen are with Guangdong Klox Biomedical Group Co., Ltd., in Guangzhou, China
| | - Michael Canova Engelbrecht Nielsen
- Dr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England
- Drs. Edge and Nielsen are with Guangdong Klox Biomedical Group Co., Ltd., in Guangzhou, China
| |
Collapse
|
4
|
Mellergaard M, Fauverghe S, Scarpa C, Pozner VL, Skov S, Hebert L, Nielsen M, Bassetto F, Téot L. Evaluation of Fluorescent Light Energy for the Treatment of Acute Second-degree Burns. Mil Med 2021; 186:416-423. [PMID: 33499452 DOI: 10.1093/milmed/usaa299] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2020] [Revised: 07/20/2020] [Accepted: 12/08/2020] [Indexed: 11/14/2022] Open
Abstract
INTRODUCTION The use of photobiomodulation has been proposed to improve wound healing for the last two decades. Recent development in photobiomodulation has led to the development of a novel biophotonic platform that utilizes fluorescent light energy (FLE) within the visible spectrum of light for healing of skin inflammation and wounds. MATERIALS AND METHODS In this article, FLE was used in preliminary analysis on 18 case studies of acute second-degree burns and in a pilot study using an ex vivo human skin model. Efficacy of FLE on wound healing and tissue remodeling was evaluated by monitoring improvements in the treated tissues, assessing pain for the patients, and by performing human genome microarray analysis of FLE-treated human skin samples. RESULTS Healing was reported for all 18 patients treated with FLE for acute second-degree burns without reported adverse effects or development of infections. Furthermore, preliminary ex vivo skin model data suggest that FLE impacts different cellular pathways including essential immune-modulatory mechanisms. CONCLUSIONS The results presented in this article are encouraging and suggest that FLE balances different stages of wound healing, which opens the door to initiating randomized controlled clinical trials for establishing the efficacy of FLE treatment in different phases of wound healing of second-degree burns.
Collapse
Affiliation(s)
- Maiken Mellergaard
- Klox Technologies, 2750 Ballerup, Denmark.,Immunology, Faculty of Health and Medical Sciences, University of Copenhagen, 1870 Frederiksberg C, Denmark
| | | | - Carlotta Scarpa
- Clinic of Plastic and Reconstructive Surgery, Padova University-Hospital, 35121 Padova, Italy
| | - Vladimir Luca Pozner
- Plastic Surgery Department, Burn Unit, University-Hospital Montpellier, 34295 Montpellier, France
| | - Søren Skov
- Immunology, Faculty of Health and Medical Sciences, University of Copenhagen, 1870 Frederiksberg C, Denmark
| | - Lise Hebert
- Klox Technologies, Inc., Laval, Quebec H7V 4A7, Canada
| | | | - Franco Bassetto
- Clinic of Plastic and Reconstructive Surgery, Padova University-Hospital, 35121 Padova, Italy
| | - Luc Téot
- Plastic Surgery Department, Burn Unit, University-Hospital Montpellier, 34295 Montpellier, France
| |
Collapse
|
5
|
Russo A, Mellergaard M, Pellacani G, Nisticò S, Nielsen MCE. Fluorescent light energy combined with systemic isotretinoin: A 52-week follow-up evaluating efficacy and safety in treatment of moderate-severe acne. Clin Case Rep 2021; 9:2057-2068. [PMID: 33936640 PMCID: PMC8077247 DOI: 10.1002/ccr3.3944] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2020] [Revised: 01/22/2021] [Accepted: 02/02/2021] [Indexed: 12/04/2022] Open
Abstract
Fluorescent light energy therapy combined with low-dose isotretinoin or tetracycline show remarkable clinical effect on 12 cases of moderate-to-severe acne. Treatment was considered safe, well-tolerated, and highly efficacious.
Collapse
Affiliation(s)
- Antonio Russo
- Department of MedicalSurgical and Neuro SciencesDermatological SectionUniversity of SienaSienaItaly
| | - Maiken Mellergaard
- ImmunologyFaculty of Health and Medical SciencesUniversity of CopenhagenFrederiksberg CDenmark
- Klox Technologies EuropeDublinIreland
| | - Giovanni Pellacani
- Department of DermatologyUniversity of Modena and Reggio EmiliaModenaItaly
| | - Steven Nisticò
- Department of Health Sciences, Unit of DermatologyMagna Graecia UniversityCatanzaroItaly
| | | |
Collapse
|
6
|
Scarcella G, Gerber PA, Edge D, Nielsen MCE. Effective removal of solar lentigines by combination of pre- And post-fluorescent light energy treatment with picosecond laser treatment. Clin Case Rep 2020; 8:1429-1432. [PMID: 32884768 PMCID: PMC7455422 DOI: 10.1002/ccr3.2839] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2019] [Revised: 02/22/2020] [Accepted: 03/20/2020] [Indexed: 01/02/2023] Open
Abstract
We present a novel treatment for removal of SL that is efficient and enables removal or lesions not immediately visible. Kleresca® FLE technology combined with picosecond laser treatment removes SL lesions and improves skin quality and appearance.
Collapse
Affiliation(s)
| | - Peter Arne Gerber
- Department of DermatologyMedical FacultyHeinrich‐Heine University, & Dermatologie am LuegplatzDüsseldorfGermany
| | | | | |
Collapse
|
7
|
Tambella AM, Attili AR, Beribè F, Galosi M, Marchegiani A, Cerquetella M, Palumbo Piccionello A, Vullo C, Spaterna A, Fruganti A. Management of otitis externa with an led-illuminated gel: a randomized controlled clinical trial in dogs. BMC Vet Res 2020; 16:91. [PMID: 32192496 PMCID: PMC7083025 DOI: 10.1186/s12917-020-02311-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2019] [Accepted: 03/11/2020] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Canine otitis externa is a painful condition which can be challenging to treat due to difficulties in the administration of otic medication. This can be due to lack of owner compliance in the application of ear drops or due to the resentment that some dogs demonstrate when attempts are made to administer topical medication into a sensitive ear canal. The aim of the study was to assess the efficacy of a topical LED-illuminated gel (LIG) in canine otitis externa in comparison to standard of care therapy. Dogs with spontaneous otitis externa were randomly allocated in three groups: groups QW received LIG once weekly; BW received LIG twice weekly; group C received enrofloxacin and silver sulfadiazine twice daily. LIG consists of a topical application of a gel containing chromophores that, when illuminated by a LED lamp, re-emit fluorescent light which can stimulate physiological responses, promoting healing and controlling bacteria. The evaluation protocol (T0 to T5) considered clinical assessment (OTIS-3-index-scoring-system; pruritus-severity-scale; pain-severity-score; aural temperature), cytological scoring system, quali-quantitative bacteriologic assessment. RESULTS All groups (QW, n = 21; BW, n = 23; C, n = 20) showed improvement during the study (QW: P < 0.02 for cytological and pain scores, P < 0.003 for bacteriologic assessment, P < 10- 4 for pruritus, total OTIS-3 and temperature assessments; BW: P < 10- 4 for all clinical, cytological and bacteriologic assessments; C: P < 0.02 for all clinical and cytological assessments, P < 10- 4 for bacteriologic assessment). The highest clinical score reduction occurred in Group BW (P < 0.014 in T3; P < 0.001 in T4 and P < 10- 4 in T5). BW reached the clinically relevant effect level at T3 (- 3.26 ± 1.21 levels), QW reached it at T4 (- 3.24 ± 0.99), C did not reach it. No differences between groups were seen in the reduction of CFU/mL (T0-T5). CONCLUSIONS All treatment groups showed a positive clinical effect. LIG administered twice-a-week was the most favourable protocol of the study. LIG may be considered beneficial in the management of canine otitis externa; it seems to be effective in controlling the clinical condition, including the signs of inflammation and local pain, the bacterial growth, and it may help increasing treatment compliance.
Collapse
Affiliation(s)
- Adolfo Maria Tambella
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione, 93/95, 62024 Matelica, MC Italy
| | - Anna Rita Attili
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione, 93/95, 62024 Matelica, MC Italy
| | - Francesca Beribè
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione, 93/95, 62024 Matelica, MC Italy
| | - Margherita Galosi
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione, 93/95, 62024 Matelica, MC Italy
| | - Andrea Marchegiani
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione, 93/95, 62024 Matelica, MC Italy
| | - Matteo Cerquetella
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione, 93/95, 62024 Matelica, MC Italy
| | - Angela Palumbo Piccionello
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione, 93/95, 62024 Matelica, MC Italy
| | - Cecilia Vullo
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione, 93/95, 62024 Matelica, MC Italy
| | - Andrea Spaterna
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione, 93/95, 62024 Matelica, MC Italy
| | - Alessandro Fruganti
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione, 93/95, 62024 Matelica, MC Italy
| |
Collapse
|
8
|
Koceva I, Rümmelein B, Gerber PA, Edge D, Nielsen MCE. Fluorescent light energy: A new therapeutic approach to effectively treating acne conglobata and hidradenitis suppurativa. Clin Case Rep 2019; 7:1769-1772. [PMID: 31534746 PMCID: PMC6745390 DOI: 10.1002/ccr3.2334] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2019] [Accepted: 06/28/2019] [Indexed: 02/06/2023] Open
Abstract
The Kleresca® biophotonic platform utilizing fluorescent light energy (FLE) effectively treated both acne conglobata and hidradenitis suppurativa. FLE decreased the presence of inflammatory nodules, cysts, and associated erythema. It also supported a healing response to improve skin texture. FLE offers a new treatment approach to recalcitrant inflammatory skin conditions.
Collapse
Affiliation(s)
| | | | - Peter Arne Gerber
- Department of Dermatology, Medical FacultyHeinrich‐Heine UniversityDüsseldorfGermany
| | - Deirdre Edge
- FB Dermatology Denmark Limited Aps.BallerupDenmark
| | | |
Collapse
|
9
|
Edge D, Mellergaard M, Dam-Hansen C, Corell DD, Jaworska J, Scapagnini G, Nielsen MCE. FLUORESCENT LIGHT ENERGY: The Future for Treating Inflammatory Skin Conditions? THE JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY 2019; 12:E61-E68. [PMID: 31320979 PMCID: PMC6561711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Background: We have previously reported clinical efficacy with a novel form of photobiomodulation-a biophotonic platform inducing fluorescent light energy (FLE)-in both disease-affected and healthy skin; however, the cellular mechanisms remain largely unknown. Objective: This study investigated the cellular mechanism of action of FLE on key skin and immune cells. Methods: We examined the effects of FLE on the clinical presentation of inflammation in a representative patient with acne vulgaris. The effect of FLE and an FLE-mimicking control lamp on collagen production from primary human dermal fibroblast (HDF) cells was assessed in the presence and absence of the proinflammatory cytokine, interferon gamma (IFN-γ). Cytokine production was assessed from HDF and human epidermal keratinocytes (HEK) exposed to M1 macrophage-conditioned media following illumination with either a blue light-emitting diode (LED) or FLE. Finally, the effects of FLE on angiogenesis were assessed in human aortic endothelial (HAE) cells. Results: FLE reduced inflammatory lesions and associated redness in the representative acne patient. Following the resolution of inflammation there was an overall enhancement of the skin's texture. FLE enhanced collagen production from nonstressed HDF cells, decreased the inflammatory profile of HDF and HEK cells, and enhanced angiogenesis in HAE cells. Conclusion: Our results suggest FLE is capable of enhancing collagen production, modulating cutaneous inflammation, and encouraging angiogenesis. While further research is required, our findings have important implications for approaches to treating inflammatory skin conditions and achieving better aesthetic outcomes.
Collapse
Affiliation(s)
- Deirdre Edge
- Drs. Edge, Mellergaard, and Nielsen are with the Department of Research and Development at FB Dermatology, Ltd. in Ballerup, Denmark. Mellergaardis also with IVH, Immunology at the University of Copenhagen in Frederiksberg, Denmark
- Dr. Dam-Hansen and Mr. Correll are with the Department of Photonics Engineering, Technical University of Denmark, Roskilde, Denmark
- Dr. Jaworska is with Klox Technologies, Inc. in Laval, Québec, Canada
- Dr. Scapagnini is with the Department of Medicine and Health Sciences "V. Tiberio" at the University of Molise in Campobasso, Italy
| | - Maiken Mellergaard
- Drs. Edge, Mellergaard, and Nielsen are with the Department of Research and Development at FB Dermatology, Ltd. in Ballerup, Denmark. Mellergaardis also with IVH, Immunology at the University of Copenhagen in Frederiksberg, Denmark
- Dr. Dam-Hansen and Mr. Correll are with the Department of Photonics Engineering, Technical University of Denmark, Roskilde, Denmark
- Dr. Jaworska is with Klox Technologies, Inc. in Laval, Québec, Canada
- Dr. Scapagnini is with the Department of Medicine and Health Sciences "V. Tiberio" at the University of Molise in Campobasso, Italy
| | - Carsten Dam-Hansen
- Drs. Edge, Mellergaard, and Nielsen are with the Department of Research and Development at FB Dermatology, Ltd. in Ballerup, Denmark. Mellergaardis also with IVH, Immunology at the University of Copenhagen in Frederiksberg, Denmark
- Dr. Dam-Hansen and Mr. Correll are with the Department of Photonics Engineering, Technical University of Denmark, Roskilde, Denmark
- Dr. Jaworska is with Klox Technologies, Inc. in Laval, Québec, Canada
- Dr. Scapagnini is with the Department of Medicine and Health Sciences "V. Tiberio" at the University of Molise in Campobasso, Italy
| | - Dennis Dan Corell
- Drs. Edge, Mellergaard, and Nielsen are with the Department of Research and Development at FB Dermatology, Ltd. in Ballerup, Denmark. Mellergaardis also with IVH, Immunology at the University of Copenhagen in Frederiksberg, Denmark
- Dr. Dam-Hansen and Mr. Correll are with the Department of Photonics Engineering, Technical University of Denmark, Roskilde, Denmark
- Dr. Jaworska is with Klox Technologies, Inc. in Laval, Québec, Canada
- Dr. Scapagnini is with the Department of Medicine and Health Sciences "V. Tiberio" at the University of Molise in Campobasso, Italy
| | - Joanna Jaworska
- Drs. Edge, Mellergaard, and Nielsen are with the Department of Research and Development at FB Dermatology, Ltd. in Ballerup, Denmark. Mellergaardis also with IVH, Immunology at the University of Copenhagen in Frederiksberg, Denmark
- Dr. Dam-Hansen and Mr. Correll are with the Department of Photonics Engineering, Technical University of Denmark, Roskilde, Denmark
- Dr. Jaworska is with Klox Technologies, Inc. in Laval, Québec, Canada
- Dr. Scapagnini is with the Department of Medicine and Health Sciences "V. Tiberio" at the University of Molise in Campobasso, Italy
| | - Giovanni Scapagnini
- Drs. Edge, Mellergaard, and Nielsen are with the Department of Research and Development at FB Dermatology, Ltd. in Ballerup, Denmark. Mellergaardis also with IVH, Immunology at the University of Copenhagen in Frederiksberg, Denmark
- Dr. Dam-Hansen and Mr. Correll are with the Department of Photonics Engineering, Technical University of Denmark, Roskilde, Denmark
- Dr. Jaworska is with Klox Technologies, Inc. in Laval, Québec, Canada
- Dr. Scapagnini is with the Department of Medicine and Health Sciences "V. Tiberio" at the University of Molise in Campobasso, Italy
| | - Michael Canova Engelbrecht Nielsen
- Drs. Edge, Mellergaard, and Nielsen are with the Department of Research and Development at FB Dermatology, Ltd. in Ballerup, Denmark. Mellergaardis also with IVH, Immunology at the University of Copenhagen in Frederiksberg, Denmark
- Dr. Dam-Hansen and Mr. Correll are with the Department of Photonics Engineering, Technical University of Denmark, Roskilde, Denmark
- Dr. Jaworska is with Klox Technologies, Inc. in Laval, Québec, Canada
- Dr. Scapagnini is with the Department of Medicine and Health Sciences "V. Tiberio" at the University of Molise in Campobasso, Italy
| |
Collapse
|
10
|
Liu RC, Makhija M, Wong XL, Sebaratnam DF. Treatment of granulomatous rosacea with chromophore gel-assisted phototherapy. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE 2019; 35:280-281. [PMID: 30854732 PMCID: PMC6849725 DOI: 10.1111/phpp.12463] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/05/2018] [Revised: 02/11/2019] [Accepted: 03/05/2019] [Indexed: 11/29/2022]
Affiliation(s)
- Rose C Liu
- University of Sydney, Camperdown, New South Wales, Australia
| | - Mani Makhija
- Kossard Dermatopathologists, Macquarie Park, New South Wales, Australia
| | - Xin L Wong
- University of New South Wales, Kensington, New South Wales, Australia
| | | |
Collapse
|